ArticleTranslational cancer research2022

Short-term outcomes of neoadjuvant sintilimab with chemotherapy in stage III non-small cell lung cancer: a case series.

Bo-Shi Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.